TDR Targets

Basic information

Technical information

TDR Targets ID: 1237657
Name: 1-(2-hydroxy-4-morpholin-4-ylphenyl)ethanone
MW: 221.252 | Formula: C12H15NO3
H donors: 1 H acceptors: 2 LogP: 1.55 Rotable bonds: 2
Rule of 5 violations (Lipinski): 1
SMILES: CC(=O)c1ccc(cc1O)N1CCOCC1
InChi: 1S/C12H15NO3/c1-9(14)11-3-2-10(8-12(11)15)13-4-6-16-7-5-13/h2-3,8,15H,4-7H2,1H3
InChiKey: YHKSBKQXCWHTQL-UHFFFAOYSA-N

Network

Hover on a compound node to display the structore

Target Layer

Model Organisms

Species	Viewmode
Arabidopsis thaliana
Caenorhabditis elegans
Dictyostelium discoideum
Drosophila melanogaster
Escherichia coli
Homo sapiens
Mus musculus
Oryza sativa
Saccharomyces cerevisiae
Schmidtea mediterranea
Other organisms

TDR Pathogens:

Species	Viewmode
Brugia malayi
Chlamydia trachomatis
Echinococcus granulosus
Entamoeba histolytica
Echinococcus multilocularis
Giardia lamblia
Leishmania major
Loa Loa (eye worm)
Mycobacterium leprae
Mycobacterium tuberculosis
Mycobacterium ulcerans
Onchocerca volvulus
Plasmodium falciparum
Plasmodium vivax
Schistosoma mansoni
Trypanosoma brucei
Trypanosoma cruzi
Toxoplasma gondii
Treponema pallidum
Trichomonas vaginalis
Wolbachia endosymbiont of Brugia malayi

Other Pathogens:

Species	Viewmode
Babesia bovis
Candida albicans
Cryptosporidium hominis
Cryptosporidium parvum
Leishmania braziliensis
Leishmania donovani
Leishmania infantum
Leishmania mexicana
Neospora caninum
Plasmodium berghei
Plasmodium knowlesi
Plasmodium yoelii
Schistosoma japonicum
Trypanosoma brucei gambiense
Trypanosoma congolense
Theileria parva

Compound Layer

This is a work in progress. Come back soon to try this features!

Clustering layers

This is a work in progress. Come back soon to try this features!

Synonyms

1-(2-hydroxy-4-morpholino-phenyl)ethanone
1-(2-hydroxy-4-morpholinophenyl)ethanone
1-(2-hydroxy-4-morpholin-4-yl-phenyl)ethanone
I2159_SIGMA
IC86621
NCGC00165807-01
DNA-PK Inhibitor III

Targets

Known targets for this compound

Species	Target name	Source	Bibliographic reference
Mus musculus	protein kinase, DNA activated, catalytic polypeptide	Starlite/ChEMBL	References
Homo sapiens	APEX nuclease (multifunctional DNA repair enzyme) 1	Starlite/ChEMBL	No references
Homo sapiens	protein kinase, DNA-activated, catalytic polypeptide	Starlite/ChEMBL	References

Predicted pathogen targets for this compound

By orthology

Species	Potential target	Known druggable target/s	Ortholog Group
Wolbachia endosymbiont of Brugia malayi	exonuclease III	Get druggable targets OG5_126768	All targets in OG5_126768
Schistosoma mansoni	ap endonuclease	Get druggable targets OG5_126768	All targets in OG5_126768
Trichomonas vaginalis	ap endonuclease, putative	Get druggable targets OG5_126768	All targets in OG5_126768
Schistosoma japonicum	DNA-(apurinic or apyrimidinic site) lyase 2, putative	Get druggable targets OG5_126768	All targets in OG5_126768
Schistosoma japonicum	DNA-(apurinic or apyrimidinic site) lyase 2, putative	Get druggable targets OG5_126768	All targets in OG5_126768
Leishmania major	apurinic/apyrimidinic endonuclease-redox protein	Get druggable targets OG5_126768	All targets in OG5_126768
Leishmania infantum	apurinic/apyrimidinic endonuclease-redox protein	Get druggable targets OG5_126768	All targets in OG5_126768
Trypanosoma congolense	apurinic/apyrimidinic endonuclease, putative	Get druggable targets OG5_126768	All targets in OG5_126768
Theileria parva	hypothetical protein	Get druggable targets OG5_126768	All targets in OG5_126768
Trichomonas vaginalis	ap endonuclease, putative	Get druggable targets OG5_126768	All targets in OG5_126768
Plasmodium falciparum	AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative	Get druggable targets OG5_126768	All targets in OG5_126768
Schistosoma mansoni	ap endonuclease	Get druggable targets OG5_126768	All targets in OG5_126768
Candida albicans	similar to S. cerevisiae APN2 (YBL019W) DNA repair apurinic/apyrimidinic endonuclease	Get druggable targets OG5_126768	All targets in OG5_126768
Echinococcus multilocularis	DNA (apurinic or apyrimidinic site) lyase	Get druggable targets OG5_126768	All targets in OG5_126768
Trypanosoma brucei gambiense	apurinic/apyrimidinic endonuclease, putative	Get druggable targets OG5_126768	All targets in OG5_126768
Neospora caninum	hypothetical protein	Get druggable targets OG5_126768	All targets in OG5_126768
Plasmodium vivax	AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative	Get druggable targets OG5_126768	All targets in OG5_126768
Giardia lamblia	Endonuclease/Exonuclease/phosphatase	Get druggable targets OG5_126768	All targets in OG5_126768
Mycobacterium ulcerans	exodeoxyribonuclease III protein XthA	Get druggable targets OG5_126768	All targets in OG5_126768
Trypanosoma cruzi	apurinic/apyrimidinic endonuclease, putative	Get druggable targets OG5_126768	All targets in OG5_126768
Echinococcus granulosus	DNA dependent protein kinase catalytic subunit	Get druggable targets OG5_132688	All targets in OG5_132688
Trypanosoma brucei	apurinic/apyrimidinic endonuclease, putative	Get druggable targets OG5_126768	All targets in OG5_126768
Plasmodium knowlesi	AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative	Get druggable targets OG5_126768	All targets in OG5_126768
Leishmania donovani	apurinic/apyrimidinic endonuclease-redox protein	Get druggable targets OG5_126768	All targets in OG5_126768
Leishmania mexicana	apurinic/apyrimidinic endonuclease-redox protein,AP-endonuclease	Get druggable targets OG5_126768	All targets in OG5_126768
Entamoeba histolytica	exodeoxyribonuclease III, putative	Get druggable targets OG5_126768	All targets in OG5_126768
Candida albicans	similar to S. cerevisiae APN2 (YBL019W) DNA repair apurinic/apyrimidinic endonuclease	Get druggable targets OG5_126768	All targets in OG5_126768
Echinococcus multilocularis	DNA dependent protein kinase catalytic subunit	Get druggable targets OG5_132688	All targets in OG5_132688
Echinococcus granulosus	DNA apurinic or apyrimidinic site lyase	Get druggable targets OG5_126768	All targets in OG5_126768
Brugia malayi	exodeoxyribonuclease III family protein	Get druggable targets OG5_126768	All targets in OG5_126768
Loa Loa (eye worm)	exodeoxyribonuclease III family protein	Get druggable targets OG5_126768	All targets in OG5_126768
Mycobacterium tuberculosis	Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI)	Get druggable targets OG5_126768	All targets in OG5_126768
Plasmodium berghei	AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative	Get druggable targets OG5_126768	All targets in OG5_126768
Toxoplasma gondii	exonuclease III APE	Get druggable targets OG5_126768	All targets in OG5_126768
Treponema pallidum	exodeoxyribonuclease (exoA)	Get druggable targets OG5_126768	All targets in OG5_126768
Schistosoma japonicum	ko:K10772 AP endonuclease 2, putative	Get druggable targets OG5_126768	All targets in OG5_126768
Plasmodium yoelii	putative AP endonuclease-related	Get druggable targets OG5_126768	All targets in OG5_126768
Cryptosporidium hominis	dna-(apurinic or apyrimidinic site) lyase	Get druggable targets OG5_126768	All targets in OG5_126768
Cryptosporidium parvum	conserved hypothetical protein	Get druggable targets OG5_126768	All targets in OG5_126768
Trypanosoma cruzi	apurinic/apyrimidinic endonuclease	Get druggable targets OG5_126768	All targets in OG5_126768
Leishmania braziliensis	apurinic/apyrimidinic endonuclease-redox protein	Get druggable targets OG5_126768	All targets in OG5_126768
Schistosoma japonicum	ko:K10771 AP endonuclease 1, putative	Get druggable targets OG5_126768	All targets in OG5_126768

By sequence similarity to non orthologous known druggable targets

No druggable targets predicted by sequence similarity

Ranking Plot

Putative Targets List

Species	Potential target	Raw	Global	Species
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Trypanosoma cruzi	hypothetical protein, conserved	0.0043	0.0461	0.1324
Echinococcus granulosus	beta LACTamase domain containing family member	0.0043	0.0461	0.0396
Mycobacterium tuberculosis	Possible penicillin-binding protein	0.0275	0.4258	1
Plasmodium falciparum	GTP-binding nuclear protein RAN/TC4	0.0025	0.0172	0.2171
Brugia malayi	Intermediate filament tail domain containing protein	0.0028	0.0211	0.1118
Echinococcus granulosus	potassium voltage gated channel subfamily H	0.0038	0.0378	0.0312
Trichomonas vaginalis	phosphofructokinase, putative	0.0035	0.0332	0.1662
Leishmania major	ATP-dependent phosphofructokinase	0.013	0.1884	0.5243
Trichomonas vaginalis	phosphofructokinase, putative	0.0035	0.0332	0.1662
Treponema pallidum	diphosphate--fructose-6-phosphate 1-phosphotransferase	0.0035	0.0332	0.1159
Trypanosoma brucei	hypothetical protein, conserved	0.0043	0.0461	0.1899
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Brugia malayi	phosphofructokinase	0.013	0.1884	1
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Leishmania major	hypothetical protein, conserved	0.0043	0.0461	0.0996
Mycobacterium leprae	PROBABLE 6-PHOSPHOFRUCTOKINASE PFKA (PHOSPHOHEXOKINASE) (PHOSPHOFRUCTOKINASE)	0.013	0.1884	1
Brugia malayi	Phosphatidylinositol 3- and 4-kinase family protein	0.0044	0.0471	0.2498
Echinococcus multilocularis	importin subunit beta 1	0.0035	0.0321	0.0255
Trypanosoma brucei	FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative	0.0027	0.0205	0.0441
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0025	0.0159	0.0737
Mycobacterium tuberculosis	Probable lipase LipD	0.0043	0.0461	0.0807
Echinococcus multilocularis	DNA (apurinic or apyrimidinic site) lyase	0.0023	0.0128	0.006
Trichomonas vaginalis	penicillin-binding protein, putative	0.0043	0.0461	0.236
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Mycobacterium tuberculosis	Probable hydrolase	0.0043	0.0461	0.0807
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0025	0.0159	0.0737
Loa Loa (eye worm)	phosphatidylinositol 3	0.0044	0.0471	0.0814
Brugia malayi	beta-lactamase	0.0043	0.0461	0.245
Trypanosoma cruzi	phosphatidylinositol kinase related protein, putative	0.0025	0.0159	0.0414
Schistosoma mansoni	family S12 unassigned peptidase (S12 family)	0.0043	0.0461	0.0689
Echinococcus granulosus	importin subunit beta 1	0.0035	0.0321	0.0255
Brugia malayi	exodeoxyribonuclease III family protein	0.0023	0.0128	0.068
Echinococcus granulosus	GTP binding nuclear protein Ran	0.0025	0.0172	0.0105
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Entamoeba histolytica	phosphatidylinositol3-kinaseTor2, putative	0.0044	0.0471	0.1951
Schistosoma mansoni	ran	0.0025	0.0172	0.0182
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Schistosoma mansoni	ap endonuclease	0.0023	0.0128	0.0105
Trypanosoma brucei	phosphatidylinositol 4-kinase, putative	0.0044	0.0471	0.1951
Entamoeba histolytica	hypothetical protein	0.0025	0.0159	0.0179
Trypanosoma brucei	target of rapamycin kinase 3, putative	0.0044	0.0471	0.1951
Echinococcus granulosus	snurportin 1	0.0369	0.578	0.5751
Leishmania major	phosphatidylinositol 3-related kinase, putative	0.0044	0.0471	0.1023
Leishmania major	importin beta-1 subunit, putative	0.0028	0.0214	0.0258
Echinococcus granulosus	phosphatidylinositol 3 and 4 kinase	0.0044	0.0471	0.0405
Trichomonas vaginalis	phosphofructokinase, putative	0.0035	0.0332	0.1662
Leishmania major	target of rapamycin (TOR) kinase 1, putative	0.0044	0.0471	0.1023
Schistosoma mansoni	lamin	0.0028	0.0211	0.025
Loa Loa (eye worm)	hypothetical protein	0.0027	0.0202	0.035
Plasmodium vivax	GTP-binding nuclear protein RAN/TC4, putative	0.0025	0.0172	0.1325
Loa Loa (eye worm)	hypothetical protein	0.0043	0.0461	0.0798
Trypanosoma cruzi	apurinic/apyrimidinic endonuclease, putative	0.0023	0.0128	0.0319
Mycobacterium tuberculosis	Possible conserved lipoprotein LpqK	0.0043	0.0461	0.0807
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Mycobacterium tuberculosis	Probable lipase LipE	0.0043	0.0461	0.0807
Leishmania major	target of rapamycin kinase (TOR) kinase 3	0.0044	0.0471	0.1023
Entamoeba histolytica	phosphofructokinase, putative	0.013	0.1884	1
Entamoeba histolytica	Phosphatidylinositol 3- and 4-kinase family	0.0025	0.0159	0.0179
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0025	0.0159	0.0737
Treponema pallidum	diphosphate--fructose-6-phosphate 1-phosphotransferase	0.013	0.1884	1
Trichomonas vaginalis	voltage and ligand gated potassium channel, putative	0.0035	0.0337	0.169
Brugia malayi	GTP-binding nuclear protein RAN/TC4	0.0025	0.0172	0.0914
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Toxoplasma gondii	ABC1 family protein	0.0043	0.0461	0.9733
Onchocerca volvulus		0.0043	0.0461	1
Mycobacterium tuberculosis	Probable esterase LipL	0.0043	0.0461	0.0807
Schistosoma mansoni	fkbp-rapamycin associated protein	0.0025	0.0159	0.016
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Brugia malayi	Phosphatidylinositol 3- and 4-kinase family protein	0.0025	0.0159	0.0846
Trichomonas vaginalis	phosphofructokinase, putative	0.0035	0.0332	0.1662
Echinococcus multilocularis	beta LACTamase domain containing family member	0.0043	0.0461	0.0396
Brugia malayi	Phosphatidylinositol 3- and 4-kinase family protein	0.0044	0.0471	0.2498
Schistosoma mansoni	phosphatidylinositol 3-and 4-kinase	0.0044	0.0471	0.0705
Mycobacterium tuberculosis	Probable conserved lipoprotein	0.0043	0.0461	0.0807
Leishmania major	GTP-binding protein, putative	0.0025	0.0172	0.0132
Schistosoma mansoni	hypothetical protein	0.0203	0.3073	0.526
Chlamydia trachomatis	fructose-6-phosphate phosphotransferase	0.0035	0.0332	0.5
Loa Loa (eye worm)	hypothetical protein	0.0043	0.0461	0.0798
Mycobacterium ulcerans	esterase/lipase LipP	0.0043	0.0461	0.1899
Trichomonas vaginalis	conserved hypothetical protein	0.0019	0.0068	0.0247
Trichomonas vaginalis	6-phosphofructokinase, putative	0.0035	0.0332	0.1662
Trypanosoma cruzi	ATP-dependent 6-phosphofructokinase, glycosomal	0.013	0.1884	0.5612
Trichomonas vaginalis	phosphofructokinase, putative	0.013	0.1884	1
Trichomonas vaginalis	conserved hypothetical protein	0.0027	0.0205	0.0984
Echinococcus multilocularis	lamin dm0	0.0028	0.0211	0.0144
Echinococcus multilocularis	GTP binding nuclear protein Ran	0.0025	0.0172	0.0105
Echinococcus granulosus	6 phosphofructokinase	0.013	0.1884	0.1828
Trypanosoma cruzi	target of rapamycin kinase 3	0.0044	0.0471	0.1352
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Toxoplasma gondii	phosphofructokinase domain-containing protein	0.0035	0.0332	0.5942
Trichomonas vaginalis	phosphofructokinase, putative	0.013	0.1884	1
Echinococcus multilocularis	FKBP12 rapamycin complex associated protein	0.0044	0.0471	0.0405
Loa Loa (eye worm)	phosphatidylinositol 3	0.0044	0.0471	0.0814
Mycobacterium ulcerans	beta-lactamase	0.0043	0.0461	0.1899
Toxoplasma gondii	HEAT repeat-containing protein	0.0035	0.0321	0.5638
Loa Loa (eye worm)	hypothetical protein	0.0043	0.0461	0.0798
Echinococcus multilocularis	6 phosphofructokinase	0.013	0.1884	0.1828
Trichomonas vaginalis	D-aminoacylase, putative	0.0043	0.0461	0.236
Plasmodium falciparum	ATP-dependent 6-phosphofructokinase	0.0035	0.0332	1
Trypanosoma cruzi	Phosphatidylinositol 3-kinase tor2	0.0044	0.0471	0.1352
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0025	0.0159	0.0737
Loa Loa (eye worm)	hypothetical protein	0.0025	0.0159	0.0276
Loa Loa (eye worm)	6-phosphofructokinase	0.013	0.1884	0.3259
Plasmodium vivax	importin-beta 2, putative	0.0035	0.0321	0.5793
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Loa Loa (eye worm)	hypothetical protein	0.0019	0.0068	0.0118
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Loa Loa (eye worm)	voltage and ligand gated potassium channel	0.0038	0.0378	0.0653
Mycobacterium ulcerans	fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE	0.0043	0.0461	0.1899
Trichomonas vaginalis	phosphofructokinase, putative	0.0035	0.0332	0.1662
Echinococcus multilocularis	snurportin 1	0.0369	0.578	0.5751
Trypanosoma cruzi	hypothetical protein, conserved	0.0043	0.0461	0.1324
Mycobacterium ulcerans	hypothetical protein	0.0043	0.0461	0.1899
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Toxoplasma gondii	GTP-binding nuclear protein ran/tc4	0.0025	0.0172	0.129
Echinococcus multilocularis	geminin	0.0203	0.3073	0.3025
Schistosoma mansoni	importin beta-1	0.0035	0.0321	0.0443
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0025	0.0159	0.0737
Echinococcus granulosus	intermediate filament protein	0.0028	0.0211	0.0144
Trichomonas vaginalis	D-aminoacylase, putative	0.0043	0.0461	0.236
Giardia lamblia	GTP-binding nuclear protein RAN/TC4	0.0025	0.0172	0.129
Trypanosoma cruzi	phosphatidylinositol 3-kinase, putative	0.0025	0.0159	0.0414
Trypanosoma brucei	importin beta-1 subunit, putative	0.0035	0.0321	0.11
Trypanosoma brucei	GTP-binding nuclear protein rtb2, putative	0.0025	0.0172	0.0252
Loa Loa (eye worm)	intermediate filament tail domain-containing protein	0.0028	0.0211	0.0364
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Trypanosoma brucei	phosphatidylinositol 3-kinase, putative	0.0044	0.0471	0.1951
Echinococcus granulosus	lamin dm0	0.0028	0.0211	0.0144
Loa Loa (eye worm)	hypothetical protein	0.0028	0.0211	0.0364
Plasmodium vivax	6-phosphofructokinase, putative	0.0035	0.0332	0.6104
Trypanosoma cruzi	hypothetical protein, conserved	0.0219	0.334	1
Trichomonas vaginalis	penicillin-binding protein, putative	0.0043	0.0461	0.236
Mycobacterium ulcerans	6-phosphofructokinase	0.013	0.1884	1
Schistosoma mansoni	voltage-gated potassium channel	0.0041	0.0435	0.0642
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Schistosoma mansoni	ap endonuclease	0.0023	0.0128	0.0105
Mycobacterium ulcerans	lipase LipD	0.0043	0.0461	0.1899
Trichomonas vaginalis	ap endonuclease, putative	0.0023	0.0128	0.0569
Entamoeba histolytica	pyrophosphate-dependent phosphofructokinase	0.0035	0.0332	0.1159
Trypanosoma brucei	phosphatidylinositol 3-related kinase, putative	0.0044	0.0471	0.1951
Trypanosoma brucei	importin beta-1 subunit, putative	0.0035	0.0321	0.11
Onchocerca volvulus		0.0043	0.0461	1
Schistosoma mansoni	hypothetical protein	0.0369	0.578	1
Toxoplasma gondii	phosphofructokinase PFKII	0.0035	0.0332	0.5942
Loa Loa (eye worm)	hypothetical protein	0.0043	0.0461	0.0798
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Echinococcus granulosus	lamin	0.0028	0.0211	0.0144
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Loa Loa (eye worm)	hypothetical protein	0.0043	0.0461	0.0798
Schistosoma mansoni	ataxia telangiectasia mutated (atm)-related	0.0044	0.0471	0.0705
Toxoplasma gondii	non-specific serine/threonine protein kinase	0.0027	0.0205	0.2259
Loa Loa (eye worm)	hypothetical protein	0.0035	0.0321	0.0556
Trichomonas vaginalis	voltage and ligand gated potassium channel, putative	0.0035	0.0337	0.169
Echinococcus granulosus	serine:threonine protein kinase SMG1	0.0025	0.0159	0.0092
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0025	0.0159	0.0737
Plasmodium vivax	6-phosphofructokinase, putative	0.0035	0.0332	0.6104
Mycobacterium tuberculosis	Probable 6-phosphofructokinase PfkA (phosphohexokinase) (phosphofructokinase)	0.013	0.1884	0.4252
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Trichomonas vaginalis	ap endonuclease, putative	0.0023	0.0128	0.0569
Echinococcus granulosus	FKBP12 rapamycin complex associated protein	0.0044	0.0471	0.0405
Brugia malayi	beta-lactamase family protein	0.0043	0.0461	0.245
Leishmania major	hypothetical protein, conserved	0.0228	0.3477	1
Loa Loa (eye worm)	exodeoxyribonuclease III family protein	0.0023	0.0128	0.0221
Loa Loa (eye worm)	nucleolar RNA-associated protein alpha	0.0369	0.578	1
Loa Loa (eye worm)	hypothetical protein	0.0043	0.0461	0.0798
Toxoplasma gondii	FATC domain-containing protein	0.0025	0.0159	0.0917
Trypanosoma brucei	phosphatidylinositol kinase related protein, putative	0.0025	0.0159	0.0179
Echinococcus multilocularis	DNA dependent protein kinase catalytic subunit	0.0627	1	1
Brugia malayi	RNA, U transporter 1	0.0098	0.1361	0.7227
Giardia lamblia	GTOR	0.0044	0.0471	1
Echinococcus multilocularis	serine protein kinase ATM	0.0025	0.0159	0.0092
Loa Loa (eye worm)	beta-LACTamase domain containing family member	0.0043	0.0461	0.0798
Trichomonas vaginalis	phosphofructokinase, putative	0.013	0.1884	1
Plasmodium vivax	hypothetical protein, conserved	0.0043	0.0461	1
Trichomonas vaginalis	phosphofructokinase, putative	0.0035	0.0332	0.1662
Brugia malayi	6-phosphofructokinase	0.013	0.1884	1
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Echinococcus multilocularis	potassium voltage gated channel subfamily H	0.0038	0.0378	0.0312
Brugia malayi	FAT domain containing protein	0.0019	0.0068	0.0362
Loa Loa (eye worm)	GTP-binding nuclear protein RAN/TC4	0.0025	0.0172	0.0298
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Loa Loa (eye worm)	beta-lactamase	0.0043	0.0461	0.0798
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Loa Loa (eye worm)	hypothetical protein	0.0033	0.0296	0.0511
Trypanosoma brucei	Phosphatidylinositol 3-kinase tor1	0.0044	0.0471	0.1951
Schistosoma mansoni	6-phosphofructokinase	0.013	0.1884	0.3179
Schistosoma mansoni	lamin	0.0028	0.0211	0.025
Trypanosoma cruzi	phosphatidylinositol 3-related kinase, putative	0.0044	0.0471	0.1352
Trichomonas vaginalis	Importin beta-1 subunit, putative	0.0028	0.0214	0.1033
Trypanosoma cruzi	GTP-binding nuclear protein rtb2, putative	0.0025	0.0172	0.0452
Mycobacterium tuberculosis	Conserved protein	0.0043	0.0461	0.0807
Trichomonas vaginalis	esterase, putative	0.0043	0.0461	0.236
Trichomonas vaginalis	ran, putative	0.0025	0.0172	0.0806
Trichomonas vaginalis	Importin beta-1 subunit, putative	0.0028	0.0214	0.1033
Brugia malayi	Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog	0.0038	0.0378	0.2004
Loa Loa (eye worm)	6-phosphofructokinase	0.013	0.1884	0.3259
Brugia malayi	intermediate filament protein	0.0028	0.0211	0.1118
Trypanosoma cruzi	phosphatidylinositol 3-related kinase, putative	0.0044	0.0471	0.1352
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Brugia malayi	Importin beta-1 subunit	0.0035	0.0321	0.1705
Mycobacterium tuberculosis	Conserved protein	0.0043	0.0461	0.0807
Schistosoma mansoni	intermediate filament proteins	0.0028	0.0211	0.025
Echinococcus multilocularis	serine:threonine protein kinase SMG1	0.0025	0.0159	0.0092
Echinococcus granulosus	geminin	0.0203	0.3073	0.3025
Trichomonas vaginalis	importin beta-1, putative	0.0028	0.0214	0.1033
Echinococcus multilocularis	phosphatidylinositol 3 and 4 kinase	0.0044	0.0471	0.0405
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0025	0.0159	0.0737
Loa Loa (eye worm)	phosphofructokinase	0.013	0.1884	0.3259
Trypanosoma brucei	ATP-dependent 6-phosphofructokinase, glycosomal	0.013	0.1884	1
Loa Loa (eye worm)	hypothetical protein	0.0027	0.0205	0.0355
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0027	0.0205	0.0984
Trichomonas vaginalis	phosphofructokinase, putative	0.013	0.1884	1
Entamoeba histolytica	phosphofructokinase, putative	0.013	0.1884	1
Echinococcus multilocularis	lamin	0.0028	0.0211	0.0144
Chlamydia trachomatis	fructose-6-phosphate phosphotransferase	0.0035	0.0332	0.5
Schistosoma mansoni	voltage-gated potassium channel	0.0041	0.0435	0.0642
Loa Loa (eye worm)	intermediate filament protein	0.0028	0.0211	0.0364
Plasmodium falciparum	importin beta, putative	0.0035	0.0321	0.9489
Brugia malayi	6-phosphofructokinase	0.013	0.1884	1
Wolbachia endosymbiont of Brugia malayi	exonuclease III	0.0023	0.0128	0.5
Mycobacterium tuberculosis	Probable esterase/lipase LipP	0.0043	0.0461	0.0807
Loa Loa (eye worm)	hypothetical protein	0.0016	0.0022	0.0038
Entamoeba histolytica	hypothetical protein	0.0028	0.0214	0.0492
Brugia malayi	Phosphatidylinositol 3- and 4-kinase family protein	0.0025	0.0159	0.0846
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0025	0.0159	0.0737
Mycobacterium tuberculosis	Conserved protein	0.0043	0.0461	0.0807
Entamoeba histolytica	Ran family GTPase	0.0025	0.0172	0.0252
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Schistosoma mansoni	hypothetical protein	0.0203	0.3073	0.526
Onchocerca volvulus		0.0043	0.0461	1
Echinococcus granulosus	serine protein kinase ATM	0.0025	0.0159	0.0092
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Entamoeba histolytica	FKBP-rapamycin associated protein (FRAP), putative	0.0044	0.0471	0.1951
Giardia lamblia	Pyrophosphate-fructose 6-phosphate 1-phosphotransferase alpha subunit	0.0035	0.0332	0.5942
Trypanosoma cruzi	apurinic/apyrimidinic endonuclease	0.0023	0.0128	0.0319
Toxoplasma gondii	6-phosphofructokinase	0.0035	0.0332	0.5942
Echinococcus granulosus	DNA apurinic or apyrimidinic site lyase	0.0023	0.0128	0.006
Schistosoma mansoni	ran	0.0025	0.0172	0.0182
Leishmania major	target of rapamycin (TOR) kinase 2, putative	0.0044	0.0471	0.1023
Brugia malayi	Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative	0.0043	0.0461	0.245
Entamoeba histolytica	protein kinase rad3, putative	0.0025	0.0159	0.0179
Schistosoma mansoni	family S12 unassigned peptidase (S12 family)	0.0043	0.0461	0.0689
Trypanosoma cruzi	GTP-binding nuclear protein rtb2, putative	0.0025	0.0172	0.0452
Entamoeba histolytica	phosphofructokinase, putative	0.013	0.1884	1
Trypanosoma cruzi	Phosphatidylinositol 3-kinase tor1	0.0044	0.0471	0.1352
Brugia malayi	beta-lactamase family protein	0.0043	0.0461	0.245
Trichomonas vaginalis	D-aminoacylase, putative	0.0043	0.0461	0.236
Leishmania major	phosphatidylinositol 3-kinase, putative	0.0044	0.0471	0.1023
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Plasmodium falciparum	ATP-dependent 6-phosphofructokinase	0.0035	0.0332	1
Toxoplasma gondii	target of rapamycin (TOR), putative	0.0044	0.0471	1
Schistosoma mansoni	ataxia telangiectasia mutated (atm)	0.0025	0.0159	0.016
Trypanosoma cruzi	importin beta-1 subunit, putative	0.0028	0.0214	0.058
Schistosoma mansoni	6-phosphofructokinase	0.013	0.1884	0.3179
Trichomonas vaginalis	PIKK family atypical protein kinase	0.0044	0.0471	0.2409
Echinococcus multilocularis	musashi	0.0028	0.0211	0.0144

Activities

Activity type	Activity value	Assay description	Source	Reference
IC50 (binding)	= 120 nM	Inhibition of DNA-PK in C57BL6 mouse endothelial cells	ChEMBL.	22835870
IC50 (binding)	= 120 nM	Inhibition of DNA-PK purified from HeLa nuclear extracts assessed as EPPLSQEAFADLWKKR peptide substrate phosphorylation	ChEMBL.	25387153
Potency (functional)	10 uM	PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory)	ChEMBL.	No reference
Residual Activity (binding)	= 5 %	Millipore: Percentage of residual kinase activity of SIK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 39 %	Millipore: Percentage of residual kinase activity of GSG2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 46 %	Millipore: Percentage of residual kinase activity of RPS6KB1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 55 %	Millipore: Percentage of residual kinase activity of RPS6KB1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 56 %	Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 62 %	Millipore: Percentage of residual kinase activity of SGK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 64 %	Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 66 %	Millipore: Percentage of residual kinase activity of SGK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 68 %	Millipore: Percentage of residual kinase activity of PLK1 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 20 mM DTT	ChEMBL.	23398362
Residual Activity (binding)	= 70 %	Millipore: Percentage of residual kinase activity of STK24 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 70 %	Millipore: Percentage of residual kinase activity of PAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 70 %	Millipore: Percentage of residual kinase activity of TBK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 71 %	Millipore: Percentage of residual kinase activity of STK24 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 73 %	Millipore: Percentage of residual kinase activity of TNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 74 %	Millipore: Percentage of residual kinase activity of DCLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 74 %	Millipore: Percentage of residual kinase activity of CDK9 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 74 %	Millipore: Percentage of residual kinase activity of TBK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 74 %	Millipore	LITERATURE.	23398362
Residual Activity (binding)	= 75 %	Millipore: Percentage of residual kinase activity of DCLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 75 %	Millipore: Percentage of residual kinase activity of MAP2K6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4, 1 mg/mL BSA	ChEMBL.	23398362
Residual Activity (binding)	= 77 %	Millipore: Percentage of residual kinase activity of NEK3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 77 %	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 77 %	Millipore: Percentage of residual kinase activity of MST1R at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 78 %	Millipore: Percentage of residual kinase activity of GSG2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 79 %	Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 80 %	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 80 %	Millipore: Percentage of residual kinase activity of MAPK8 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ? -mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 80 %	Millipore: Percentage of residual kinase activity of FYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4	ChEMBL.	23398362
Residual Activity (binding)	= 81 %	Millipore: Percentage of residual kinase activity of CSNK2A1 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 20 mM HEPES pH 7.6, 0.15 M NaCl, 0.1 mM EDTA, 5 mM DTT, 0.1% Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 81 %	Millipore: Percentage of residual kinase activity of INSR at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 81 %	Millipore: Percentage of residual kinase activity of MUSK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 81 %	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 82 %	Millipore: Percentage of residual kinase activity of PRKCE at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	ChEMBL.	23398362
Residual Activity (binding)	= 82 %	Millipore: Percentage of residual kinase activity of PIM1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 83 %	Millipore: Percentage of residual kinase activity of NLK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 83 %	Millipore: Percentage of residual kinase activity of CDK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 83 %	Millipore: Percentage of residual kinase activity of LIMK1 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 83 %	Millipore: Percentage of residual kinase activity of MYLK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 83 %	Millipore: Percentage of residual kinase activity of CAMK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 83 %	Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 83 %	Millipore: Percentage of residual kinase activity of RAF1 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 83 %	Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 83 %	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 84 %	Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	ChEMBL.	23398362
Residual Activity (binding)	= 84 %	Millipore: Percentage of residual kinase activity of CDK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 84 %	Millipore: Percentage of residual kinase activity of NEK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 84 %	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	ChEMBL.	23398362
Residual Activity (binding)	= 84 %	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 84 %	Millipore: Percentage of residual kinase activity of ZAP70 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 84 %	Millipore: Percentage of residual kinase activity of NTRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 85 %	Millipore: Percentage of residual kinase activity of MAPK10 at 10uM relative to control. Control inhibitor: JAK Inhibitor I at 30.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 85 %	Millipore: Percentage of residual kinase activity of STK4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 85 %	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 85 %	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 85 %	Millipore: Percentage of residual kinase activity of MYLK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 85 %	Millipore: Percentage of residual kinase activity of CDK9 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 85 %	Millipore: Percentage of residual kinase activity of BMX at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 85 %	Millipore: Percentage of residual kinase activity of TXK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 86 %	Millipore: Percentage of residual kinase activity of GRK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 86 %	Millipore: Percentage of residual kinase activity of FLT3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 86 %	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 86 %	Millipore: Percentage of residual kinase activity of ZAP70 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 86 %	Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 86 %	Millipore: Percentage of residual kinase activity of EEF2K at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 86 %	Millipore: Percentage of residual kinase activity of TXK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 86 %	Millipore: Percentage of residual kinase activity of TYRO3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 86 %	Millipore	LITERATURE.	23398362
Residual Activity (binding)	= 87 %	Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 87 %	Millipore: Percentage of residual kinase activity of PRKG1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 uM cGMP	ChEMBL.	23398362
Residual Activity (binding)	= 87 %	Millipore: Percentage of residual kinase activity of ROCK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 87 %	Millipore: Percentage of residual kinase activity of PIM1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 88 %	Millipore: Percentage of residual kinase activity of SRPK3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 88 %	Millipore: Percentage of residual kinase activity of MINK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 88 %	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 88 %	Millipore: Percentage of residual kinase activity of MAPK10 at 1uM relative to control. Control inhibitor: JAK Inhibitor I at 30.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 88 %	Millipore: Percentage of residual kinase activity of PASK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 88 %	Millipore	LITERATURE.	23398362
Residual Activity (binding)	= 89 %	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 89 %	Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 89 %	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 89 %	Millipore: Percentage of residual kinase activity of CDK6 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 89 %	Millipore: Percentage of residual kinase activity of LCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 89 %	Millipore: Percentage of residual kinase activity of MAP3K9 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 89 %	Millipore: Percentage of residual kinase activity of CAMK2B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 89 %	Millipore: Percentage of residual kinase activity of MAPK3 at 10uM relative to control. Control inhibitor: ERK Inhibitor II at 30.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 89 %	Millipore: Percentage of residual kinase activity of TSSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of MELK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of EPHA7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of GRK7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of PRKAA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 200 uM AMP	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of PRKAA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 200 uM AMP	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of PLK3 at 1uM relative to control. Control inhibitor: Wortmannin at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of PAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of ULK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of ULK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of SIK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 90 %	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of MAP2K6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4, 1 mg/mL BSA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of BTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of CDK7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of MAPK3 at 1uM relative to control. Control inhibitor: ERK Inhibitor II at 30.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of PIM3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.1% Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of PLK1 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 20 mM DTT	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of PAK7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of PRKCE at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of MST1R at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of TAOK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 91 %	Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of BMX at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of CAMK2B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of IGF1R at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of STK33 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of PLK3 at 10uM relative to control. Control inhibitor: Wortmannin at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of ROCK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of TAOK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 92 %	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of CSNK2A2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 20 mM HEPES pH 7.6, 0.15 M NaCl, 0.1 mM EDTA, 5 mM DTT, 0.1% Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of EPHA8 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of EPHB1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of INSRR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of CHEK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of ERBB4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of BRSK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of PAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 93 %	Millipore: Percentage of residual kinase activity of PRKCB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	ChEMBL.	23398362
Residual Activity (binding)	= 94 %	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 94 %	Millipore: Percentage of residual kinase activity of TNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 94 %	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 94 %	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 94 %	Millipore: Percentage of residual kinase activity of EPHA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 94 %	Millipore: Percentage of residual kinase activity of HIPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 94 %	Millipore: Percentage of residual kinase activity of PTK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 94 %	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 94 %	Millipore: Percentage of residual kinase activity of TSSK1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 94 %	Millipore: Percentage of residual kinase activity of TAOK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 94 %	Millipore: Percentage of residual kinase activity of ROS1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 94 %	Millipore: Percentage of residual kinase activity of WNK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of CDK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of GRK7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of IRAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of HIPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of BRSK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of TLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of SRPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of PRKX at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of PRKG1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 uM cGMP	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of PAK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 95 %	Millipore: Percentage of residual kinase activity of TAOK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl	ChEMBL.	23398362
Residual Activity (binding)	= 96 %	Millipore: Percentage of residual kinase activity of FYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4	ChEMBL.	23398362
Residual Activity (binding)	= 96 %	Millipore: Percentage of residual kinase activity of STK4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 96 %	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	ChEMBL.	23398362
Residual Activity (binding)	= 96 %	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 96 %	Millipore: Percentage of residual kinase activity of CHEK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 96 %	Millipore: Percentage of residual kinase activity of CAMK2G at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 96 %	Millipore: Percentage of residual kinase activity of JAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 96 %	Millipore: Percentage of residual kinase activity of PIM3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.1% Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 96 %	Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 96 %	Millipore: Percentage of residual kinase activity of MAPK13 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 96 %	Millipore: Percentage of residual kinase activity of VRK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of NLK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of FGFR4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of STK11 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.1% v/v Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of INSR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of CDK7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of HIPK1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of ITK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of ITK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of MAP3K9 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of CSNK1G1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of CSNK1G1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of CAMK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 40 mM HEPES pH 7.4, 5 mM CaCl2, 30 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of DAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of RAF1 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 97 %	Millipore: Percentage of residual kinase activity of PAK7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 98 %	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 98 %	Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 98 %	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 98 %	Millipore: Percentage of residual kinase activity of HIPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 98 %	Millipore: Percentage of residual kinase activity of CAMK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 40 mM HEPES pH 7.4, 5 mM CaCl2, 30 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 98 %	Millipore: Percentage of residual kinase activity of CAMK1D at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 98 %	Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 98 %	Millipore: Percentage of residual kinase activity of SRPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 98 %	Millipore: Percentage of residual kinase activity of TSSK1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 98 %	Millipore: Percentage of residual kinase activity of SRPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 98 %	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 98 %	Millipore: Percentage of residual kinase activity of ROS1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 99 %	Millipore: Percentage of residual kinase activity of CDK6 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 99 %	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 99 %	Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 99 %	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of CDK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of DAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of FER at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of MELK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of EPHA8 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of HIPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of CDK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of PAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of PRKCB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	ChEMBL.	23398362
Residual Activity (binding)	= 100 %	Millipore: Percentage of residual kinase activity of PKN2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 101 %	Millipore: Percentage of residual kinase activity of EPHA5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 101 %	Millipore: Percentage of residual kinase activity of EPHA7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 101 %	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 101 %	Millipore: Percentage of residual kinase activity of EPHB1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 101 %	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 101 %	Millipore: Percentage of residual kinase activity of MAPK9 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 101 %	Millipore: Percentage of residual kinase activity of AKT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 101 %	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	ChEMBL.	23398362
Residual Activity (binding)	= 101 %	Millipore: Percentage of residual kinase activity of SYK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 101 %	Millipore: Percentage of residual kinase activity of KIT at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 101 %	Millipore: Percentage of residual kinase activity of PRKCD at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	ChEMBL.	23398362
Residual Activity (binding)	= 101 %	Millipore: Percentage of residual kinase activity of TAOK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of IKBKB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of PRKAA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 200 uM AMP	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of JAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of FLT3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	ChEMBL.	23398362
Residual Activity (binding)	= 102 %	Millipore: Percentage of residual kinase activity of MAPK12 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 103 %	Millipore: Percentage of residual kinase activity of CAMK2G at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 103 %	Millipore: Percentage of residual kinase activity of MAPK9 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 103 %	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 103 %	Millipore: Percentage of residual kinase activity of PTK2B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 103 %	Millipore: Percentage of residual kinase activity of TAOK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl	ChEMBL.	23398362
Residual Activity (binding)	= 103 %	Millipore: Percentage of residual kinase activity of PRKCD at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	ChEMBL.	23398362
Residual Activity (binding)	= 103 %	Millipore: Percentage of residual kinase activity of TLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 103 %	Millipore	LITERATURE.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of CDK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of IKBKB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of LIMK1 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of INSR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of HIPK1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of NEK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of MAPK8 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ? -mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of CDK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of WNK3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of WNK3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of TSSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of AKT3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 104 %	Millipore: Percentage of residual kinase activity of MTOR at 1uM relative to control. Control inhibitor: Rapamycin at 10.0uM. Buffer: 50 mM HEPES pH 7.5, 1 mM EGTA, 0.01% Tween 20, 10 uM FKBP12	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of GRK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of IRAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of MET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of MUSK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of YES1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of AKT2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of RPS6KA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of STK33 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of EEF2K at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of SGK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 105 %	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of CDK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of CAMK1D at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of TYRO3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of AKT3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of PRKX at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of DAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of NTRK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of ULK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of ULK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 106 %	Millipore: Percentage of residual kinase activity of PRKCZ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of STK11 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.1% v/v Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of ERBB4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of RPS6KA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of PAK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of VRK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of PRKCZ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 107 %	Millipore: Percentage of residual kinase activity of SGK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 108 %	Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 108 %	Millipore: Percentage of residual kinase activity of CSNK2A1 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 20 mM HEPES pH 7.6, 0.15 M NaCl, 0.1 mM EDTA, 5 mM DTT, 0.1% Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 108 %	Millipore: Percentage of residual kinase activity of MINK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 108 %	Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 108 %	Millipore: Percentage of residual kinase activity of CAMK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	ChEMBL.	23398362
Residual Activity (binding)	= 108 %	Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 108 %	Millipore: Percentage of residual kinase activity of BLK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 108 %	Millipore: Percentage of residual kinase activity of RPS6KA5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 108 %	Millipore: Percentage of residual kinase activity of ABL1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 108 %	Millipore: Percentage of residual kinase activity of NTRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 108 %	Millipore: Percentage of residual kinase activity of PRKCG at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of LCK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of NEK11 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of MAPK1 at 10uM relative to control. Control inhibitor: ERK Inhibitor II at 30.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of PRKCG at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of PKN2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of SGK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 109 %	Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 110 %	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 110 %	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 110 %	Millipore: Percentage of residual kinase activity of EPHA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 110 %	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 110 %	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 110 %	Millipore: Percentage of residual kinase activity of CSF1R at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 110 %	Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 110 %	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 110 %	Millipore: Percentage of residual kinase activity of MAPK12 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 110 %	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 111 %	Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 111 %	Millipore: Percentage of residual kinase activity of CHUK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 111 %	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 111 %	Millipore: Percentage of residual kinase activity of AKT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 112 %	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 112 %	Millipore: Percentage of residual kinase activity of DMPK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 112 %	Millipore: Percentage of residual kinase activity of NEK6 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 112 %	Millipore: Percentage of residual kinase activity of MTOR at 10uM relative to control. Control inhibitor: Rapamycin at 10.0uM. Buffer: 50 mM HEPES pH 7.5, 1 mM EGTA, 0.01% Tween 20, 10 uM FKBP12	ChEMBL.	23398362
Residual Activity (binding)	= 112 %	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 113 %	Millipore: Percentage of residual kinase activity of FER at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 113 %	Millipore: Percentage of residual kinase activity of IGF1R at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	ChEMBL.	23398362
Residual Activity (binding)	= 113 %	Millipore: Percentage of residual kinase activity of INSRR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 113 %	Millipore: Percentage of residual kinase activity of LCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 113 %	Millipore: Percentage of residual kinase activity of MAPK1 at 1uM relative to control. Control inhibitor: ERK Inhibitor II at 30.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 113 %	Millipore: Percentage of residual kinase activity of ABL1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 113 %	Millipore: Percentage of residual kinase activity of YES1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 113 %	Millipore: Percentage of residual kinase activity of MAPK13 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 113 %	Millipore: Percentage of residual kinase activity of SGK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 114 %	Millipore: Percentage of residual kinase activity of PRKAA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 200 uM AMP	ChEMBL.	23398362
Residual Activity (binding)	= 114 %	Millipore: Percentage of residual kinase activity of NEK6 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 114 %	Millipore: Percentage of residual kinase activity of CHUK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 114 %	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 115 %	Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	ChEMBL.	23398362
Residual Activity (binding)	= 115 %	Millipore: Percentage of residual kinase activity of MET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 115 %	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 115 %	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 116 %	Millipore: Percentage of residual kinase activity of STK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 116 %	Millipore: Percentage of residual kinase activity of NEK11 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 116 %	Millipore: Percentage of residual kinase activity of NEK3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 116 %	Millipore: Percentage of residual kinase activity of KIT at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 116 %	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 117 %	Millipore: Percentage of residual kinase activity of EPHA5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 117 %	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 117 %	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 117 %	Millipore: Percentage of residual kinase activity of MTOR at 1uM relative to control. Control inhibitor: PI-103 at 30.0uM. Buffer: 50 mM HEPES pH 7.5, 1 mM EGTA, 0.01% Tween 20	ChEMBL.	23398362
Residual Activity (binding)	= 117 %	Millipore: Percentage of residual kinase activity of MTOR at 10uM relative to control. Control inhibitor: PI-103 at 30.0uM. Buffer: 50 mM HEPES pH 7.5, 1 mM EGTA, 0.01% Tween 20	ChEMBL.	23398362
Residual Activity (binding)	= 117 %	Millipore: Percentage of residual kinase activity of WNK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 118 %	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 118 %	Millipore: Percentage of residual kinase activity of BTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 118 %	Millipore: Percentage of residual kinase activity of SRPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 119 %	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 119 %	Millipore: Percentage of residual kinase activity of EGFR at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 119 %	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 119 %	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 120 %	Millipore: Percentage of residual kinase activity of IGF1R at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 120 %	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 120 %	Millipore: Percentage of residual kinase activity of EGFR at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 120 %	Millipore: Percentage of residual kinase activity of PTK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 120 %	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 120 %	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 120 %	Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 120 %	Millipore: Percentage of residual kinase activity of ROCK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 121 %	Millipore: Percentage of residual kinase activity of SRPK3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 121 %	Millipore: Percentage of residual kinase activity of STK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 121 %	Millipore: Percentage of residual kinase activity of DAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 121 %	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 121 %	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 121 %	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 121 %	Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 121 %	Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 121 %	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 122 %	Millipore: Percentage of residual kinase activity of INSR at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 123 %	Millipore: Percentage of residual kinase activity of CSF1R at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 123 %	Millipore: Percentage of residual kinase activity of ROCK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 124 %	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 124 %	Millipore: Percentage of residual kinase activity of STK17A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 124 %	Millipore: Percentage of residual kinase activity of PTK2B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 125 %	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 126 %	Millipore: Percentage of residual kinase activity of FGFR4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	ChEMBL.	23398362
Residual Activity (binding)	= 126 %	Millipore: Percentage of residual kinase activity of BLK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 126 %	Millipore: Percentage of residual kinase activity of NTRK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 127 %	Millipore: Percentage of residual kinase activity of STK17A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 127 %	Millipore: Percentage of residual kinase activity of PASK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 128 %	Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 128 %	Millipore: Percentage of residual kinase activity of CSNK2A2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 20 mM HEPES pH 7.6, 0.15 M NaCl, 0.1 mM EDTA, 5 mM DTT, 0.1% Triton X-100	ChEMBL.	23398362
Residual Activity (binding)	= 128 %	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	ChEMBL.	23398362
Residual Activity (binding)	= 129 %	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 129 %	Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 129 %	Millipore: Percentage of residual kinase activity of SYK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	ChEMBL.	23398362
Residual Activity (binding)	= 130 %	Millipore: Percentage of residual kinase activity of DMPK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 131 %	Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA	ChEMBL.	23398362
Residual Activity (binding)	= 133 %	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 133 %	Millipore: Percentage of residual kinase activity of RPS6KA5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 134 %	Millipore: Percentage of residual kinase activity of AKT2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	ChEMBL.	23398362
Residual Activity (binding)	= 138 %	Millipore: Percentage of residual kinase activity of LCK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4	ChEMBL.	23398362
Residual Activity (binding)	= 148 %	Millipore: Percentage of residual kinase activity of IGF1R at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	ChEMBL.	23398362

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

ChEMBL: CHEMBL1317546

Bibliographic References

3 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.

Detailed information for compound 1237657